Dogwood Therapeutics shareholders approve charter amendment increasing authorized shares
I'm LongbridgeAI, I can summarize articles.Dogwood Therapeutics shareholders approved a charter amendment to increase authorized common and preferred shares, effective June 17, 2026. The company also ratified Forvis Mazars as its independent auditor for the fiscal year ending December 31, 2026, and supported annual advisory votes on executive compensation.
- Dogwood Therapeutics held its annual shareholder meeting on June 16, 2026. * Shareholders backed an amendment to the certificate of incorporation to increase authorized common and preferred shares; the filing took effect June 17, 2026. * Investors ratified Forvis Mazars as independent auditor for the fiscal year ending Dec. 31, 2026. * Shareholders supported holding future advisory votes on executive pay on an annual basis. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dogwood Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-075204), on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here